Interconnections between apoptotic and autophagic pathways during thiopurine-induced toxicity in cancer cells: the role of reactive oxygen species.
Thiopurines (azathioprine, 6-mercaptopurine and 6-thioguanine) are a class of genotoxic drugs extensively used in the treatment of various illnesses including leukemia. Their underlying molecular mechanism of action involves the activation of apoptosis and autophagy but remains widely unclear. Here we present evidence that autophagy induction by thiopurines is a survival mechanism that antagonizes apoptosis and is involved in degrading damaged mitochondria through mitophagy. On the other hand, apoptosis is the main cell death mechanism by thiopurines as its inhibition prohibited cell death. Thus a tight interplay between apoptosis and autophagy controls cell fate in response to thiopurine treatment. Moreover, thiopurines disrupt mitochondrial function and induce a loss of the mitochondrial transmembrane potential. The involvement of the mitochondrial pathway in thiopurine-induced apoptosis was further confirmed by increased formation of reactive oxygen species (ROS). Inhibiting oxidative stress protected the cells from thiopurine-induced cell death and ROS scavenging prohibited autophagy induction by thiopurines. Our data indicate that the anticarcinogenic effects of thiopurines are mediated by complex interplay between cellular mechanisms governing redox homeostasis, apoptosis and autophagy.
Division of Drug Research, Department of Medical and Health Sciences, Linköping University, SE-58183 Linköping, Sweden.
Wiem
W
Chaabane
Division of Drug Research, Department of Medical and Health Sciences, Linköping University, SE-58183 Linköping, Sweden.
Malin Lindqvist
ML
Appell
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001343:Autophagy / Q000187:drug effects*; D001379:Azathioprine / Q000494:pharmacology; D020137:Base Pair Mismatch / Q000187:drug effects; D020169:Caspases / Q000378:metabolism; D045744:Cell Line, Tumor; D002738:Chloroquine / Q000494:pharmacology; D006801:Humans; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D063306:Mitophagy / Q000187:drug effects; D018384:Oxidative Stress / Q000187:drug effects; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013866:Thioguanine / Q000494:pharmacology*
D000964:Antimetabolites, Antineoplastic; D017382:Reactive Oxygen Species; D002738:Chloroquine; D020169:Caspases; D013866:Thioguanine; D001379:Azathioprine
6-mercaptopurine; 6-thioguanine; apoptosis; autophagy; azathioprine
Int J Biochem Cell Biol. 2004 Dec;36(12):2491-502
15325587
Biochem Pharmacol. 1990 Sep 1;40(5):1063-9
2390103
Biochimie. 2002 Feb-Mar;84(2-3):131-41
12022944
Mol Cell Biol. 2005 Feb;25(3):1025-40
15657430
Free Radic Biol Med. 2014 Jun;71:196-207
24681256
Antioxid Redox Signal. 2014 Sep 20;21(9):1422-41
24180661
Cancer Res. 2001 Sep 1;61(17 ):6555-62
11522654
FEBS J. 2010 Jan;277(1):58-65
19878312
Nat Rev Cancer. 2002 Apr;2(4):277-88
12001989
Nat Genet. 2007 Feb;39(2):207-11
17200669
J Cell Mol Med. 2011 Sep;15(9):1797-806
21564515
Autophagy. 2007 Jul-Aug;3(4):368-70
17426439
Arch Immunol Ther Exp (Warsz). 2013 Feb;61(1):43-58
23229678
J Cell Biol. 1999 Oct 18;147(2):435-46
10525546
Mucosal Immunol. 2017 Mar;10 (2):352-360
27435106
Cell Death Differ. 2003 Jun;10 (6):709-17
12761579
Science. 2004 Jun 4;304(5676):1500-2
15131264
Trends Pharmacol Sci. 1997 Jan;18(1):3-7
9114722
Cancer Res. 1953 Aug;13(8):593-604
13082494
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8698-702
9671741
Neoplasia. 2014 Sep;16(9):679-93
25246270
Genes Dev. 2003 Oct 15;17(20):2481-95
14561771
Chem Res Toxicol. 2015 Jun 15;28(6):1186-95
25928802
Clin Cancer Res. 2003 Jun;9(6):2327-34
12796402
N Engl J Med. 1963 Jun 13;268:1315-23
13936775
Autophagy. 2010 Oct;6(7):999-1005
20639698
Mol Cell. 2009 May 15;34(3):259-69
19450525
Mol Cell Proteomics. 2013 Dec;12(12):3803-11
24043426
Biochim Biophys Acta. 2011 Apr;1813(4):616-22
20888866
Cell Cycle. 2004 Sep;3(9):1124-6
15326383
Science. 1989 Apr 7;244(4900):41-7
2649979
J Clin Invest. 2006 Aug;116(8):2161-72
16886061
FEBS Lett. 2011 Dec 15;585(24):3941-6
22062154
Nat Rev Cancer. 2004 Aug;4(8):592-603
15286739
Cell. 2012 Jun 22;149(7):1536-48
22726440
Oncogene. 2007 Feb 26;26(9):1324-37
17322918
Science. 1996 Aug 23;273(5278):1109-11
8688098
Cell Death Differ. 2009 Jan;16(1):3-11
18846107
J Hepatol. 2001 Dec;35(6):756-64
11738103
J Clin Invest. 2007 Feb;117(2):326-36
17235397
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
17717517
Dev Cell. 2004 Apr;6(4):463-77
15068787
Nat Cell Biol. 2010 Sep;12 (9):836-41
20811356
Med Sci Monit. 2004 Nov;10(11):RA247-54
15507865
Dig Liver Dis. 2015 Sep;47(9):744-50
26066377